Bone-seeking agents for the treatment of bone disorders
- 6 June 2017
- journal article
- review article
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 7 (4) , 466-481
Abstract
The targeting and delivery of therapeutic and diagnostic agents to bone tissue presents both a challenge and opportunity. Osteoporosis, Paget’s disease, cancer, and bone metastases are all skeletal diseases whose treatment would benefit from new targeted therapeutic strategies. Osteoporosis, in particular, is a very prevalent disease, affecting over one in three women and one in five men in Canada alone with the cost to the healthcare system estimated at over $2.3 billion in 2010. Bone tissue is often considered a rigid structure when in reality there is a process of continuous remodeling that takes place via complex endocrine-regulated cell signaling pathways in addition to the signaling pathways unique to bone tissue. It is these specific boneremodeling processes that provide unique targeting opportunities but also present a number of challenges.Keywords
Funding Information
- Saskatchewan Health Research Foundation
This publication has 158 references indexed in Scilit:
- Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?Journal of Translational Medicine, 2013
- Nanodiamonds as novel nanomaterials for biomedical applications: drug delivery and imaging systemsInternational Journal of Nanomedicine, 2013
- The burden of illness of osteoporosis in CanadaOsteoporosis International, 2012
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind studyThe Lancet, 2011
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyJournal of Clinical Oncology, 2010
- Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failureNephrology Dialysis Transplantation, 2010
- Bisphosphonates: Mechanism of Action and Role in Clinical PracticeMayo Clinic Proceedings, 2008
- Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025Journal of Bone and Mineral Research, 2007
- Biology of RANK, RANKL, and osteoprotegerinArthritis Research & Therapy, 2007
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002